ABBV has been on an epic blast higher and is Vertical off the monthly moving averages. Looking for a round number 180, 200 or into the extreme extension above 210. Shorts should be looking to build a nice position on this with time as it continues to extend. Short back down to the Discount zone.
ABBV has benefited from institutional investors plowing into it while they force the rest of the market to fall...My guess is this will fall while they pull their money and buy quality tech at massive discounts. Today's candle looks like a top. Adding puts 3 weeks out.
AbbVie ( NYSE:ABBV ) looks weak at resistance and may be due for a drop in the coming weeks. Pretty strong bearish divergence. Insiders selling almost $16 million worth of shares in the past month at an average of $147.87 (source: OpenInsider). If this starts to drop, support points are the 50 EMA (yellow line), $135-$136, and then the support lines / 200 EMA....
We have a weak market and this one is quite holding up! Would want to see this close above 132-133 for long. Close below support - Puts. Im open to any critique. Please feel free to comment and tell me what you think!
Gaining momentum and impulsing. This is good if you are bullish on this one. COVID paranoia is doing wonders for the pharma sector. It is very rare how a whole sector can benefit so much financially from mass hysteria. We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are...
All, I mean you can't tell me this isnt a textbook double bottom if this was on 5M its a buy. Crazy on a weekly chart. Would be a huge long position and wouild have to hold. Interesting. If this bottom holds here might actually buy and hold some just to see if we can get a 3-4 PT hit.
All, LFMD had game changing fundamentals last quarter but still under downtrend resisance #2. This is a 3/4 retracement wave C should be ending RSI tells the story on the daily. I am watching EXTREMELY closely here. I think this is going to pop worst case is a double bottom at 7.7 or near it in which case I will absolutely be all in. Fundamnentally/valuation...
Welcome to our Weekly V2-Trade Setup ( ABBV ) ! - 4 HOUR Slowly rising market structure. DAILY Expecting a pushback to previous wave highs at least.. WEEKLY Great long entries! - STOCK SETUP BUY ABBV ENTRY LEVEL @ 111.19 SL @ 107.66 TP @ Open Max Risk: 0.5% - 1%! (Remember to add a few pips to all levels - different Brokers!) Leave us a comment or like to...
Moving averages show us that current trend is bullish. Price is sitting at the support level after publication of the last earnings indicating that business is doing well. So it's a nice pick up I'd like to hold it until we break the previous high at 113.35. Want more investing ideas? PM me.
$ABBV was trading lower on friday after the the FDA pushed back the review period for the company's supplemental marketing application for upadacitinib in active psoriatic arthritis. Despite the big drop, it fell right to key support (right at the bottom of a range) making a good entry here in terms of RR, having a tight stop and aiming for the top of range (gap...
ABBV - A stock worth buying the next time I bought it. Everything is in favor of this stock, from the charts, the business plan, the accounting sheet and the hedge funds that bought it. Good luck with ABBV.
ABBV is on the KEY SUPPORT. If we break it, we are going lower. ENTRY LEVELS LONG: $101.95 BE AWARE $95.91 $91.82 $82.47 STRONG BUY
NYSE:ABBV Possible Scenario: LONG Evidence: Price Action This is my idea and could be wrong 100%.
NYSE:ABBV Possible Scenario: SHORT Evidence = Overbought RSI, Options bearish activity, Bearish divergence This is my idea and could be wrong 100% * It has an announcement this week , maybe it continues the trend for two more days.
Look for a break above or below today's high or low to then go on to my upper or lower targets.
Beginning to sound like a broken record. I am enjoying seeing how the patterns more or less repeats itself within a major industry sector. Like the currencies against USD are doing a similar thing, so do major pharma stocks. Anyway, Fib goals traced, not financial advice.
☝️ Losing patent protection for a top-selling blockbuster drug is a big setback for any pharmaceutical company, but this can also give us great opportunities. They have done a great strategic-movement by acquiring Allergan. It's down 18% from last July 17 high, earnings are close. I believe, yes, it's a good moment to START doing COST-AVERAGE. The price is...